Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy

Journal of the American Academy of Nurse Practitioners

Volumn 21, Issue 5, 2009, Pages 241-249

  Kaspar, Rita Wen ^a   Allen, Hugh D ^a   Montanaro, Federica ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Dystrophin; Genetics; Muscular dystrophy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN;

ARTICLE; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETICS; HUMAN; MUTATION; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINE; PRIMARY HEALTH CARE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; DISEASE PROGRESSION; DYSTROPHIN; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE;

EID: 65449122304     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00404.x     Document Type: Article

References (61)

1. Anderson, B 2007). Echocardiography: The normal examination and echocardiographic measurement. Manly, Queensland, Australia : MGA Graphics.
2. Bernal, J., Pitta, S. R. Thatai, D 2006). Role of the renin-angiotensin-aldosterone system in diastolic heart failure: Potential for pharmacologic intervention. American Journal of Cardiovascular Drugs, 6 (6 373 381. (Pubitemid 46072393)
3. Bodor, G. S., Survant, L., Voss, E. M., Smith, S., Porterfield, D. Apple, F. S 1997). Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clinical Chemistry, 43 (3 476 484. (Pubitemid 27106483)
4. Bosser, G., Lucron, H., Lethor, J. P., Burger, G., Beltramo, F., Marie, P. Y., et al 2004). Evidence of early impairments in both right and left ventricular inotropic reserves in children with Duchenne's muscular dystrophy. American Journal of Cardiology, 93 (6 724 727. (Pubitemid 38338562)
5. Bushby, K., Muntoni, F. Bourke, J. P 2003). 107th ENMC international workshop: The management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscular Disorders, 13 (2 166 172. (Pubitemid 36140013)
6. Bushby, K., Thambyayah, M. Gardner-Medwin, D 1991). Prevalence and incidence of Becker muscular dystrophy. Lancet, 337 (8748 1022 1024.
7. Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., et al 2007). Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nature Medicine, 13 (2 204 210. (Pubitemid 46245764)
8. Constantin, B., Sebille, S. Cognard, C 2006). New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: Implications in DMD. Journal of Muscle Research and Cell Motility, 27 (5-7 375 386. (Pubitemid 44325616)
9. Corrado, G., Lissoni, A., Beretta, S., Terenghi, L., Tadeo, G., Foglia-Manzillo, G., et al 2002). Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. American Journal of Cardiology, 89 (7 838 841. (Pubitemid 34241462)
10. Davies, K. E. Nowak, K. J 2006). Molecular mechanisms of muscular dystrophies: Old and new players. National Review of Molecular and Cell Biology, 7 (10 762 773. (Pubitemid 44450460)
11. De Mello, W. C. Specht, P 2006). Chronic blockade of angiotensin II AT1-receptors increased cell-to-cell communication, reduced fibrosis and improved impulse propagation in the failing heart. Journal of the Renin-Angiotensin-Aldosterone System, 7 (4 201 205. (Pubitemid 46380769)
12. Dick, D. J., Gardner-Medwin, D., Gates, P. G., Gibson, M., Simpson, J. M. Walls, T. J 1986). A trial of flunarizine in the treatment of Duchenne muscular dystrophy. Muscle & Nerve, 9 (4 349 354. (Pubitemid 16106942)
13. Doing, A. H., Renlund, D. G. Smith, R. A 2002). Becker muscular dystrophy-related cardiomyopathy: A favorable response to medical therapy. Journal of Heart and Lung Transplantation, 21 (4 496 498. (Pubitemid 34240471)
14. Doust, J., Pietrzak, E., Dobson, A. Glasziou, P 2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review. British Medical Journal, 330 (7492 625. (Pubitemid 40444756)
15. Duboc, D., Meune, C., Lerebours, G., Devaux, J. Y., Vaksmann, G. Becane, H. M 2005). Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. Journal of the American College of Cardiology, 45 (6 855 857. (Pubitemid 40342808)
16. Duchenne, G. B. A 1872). L'electricisation localisée. In Selections from the clinical works of dr Duchenne (de Boulogne) (G. Poore, Trans 3rd ed., pp. 42 87). London : The New Sydenham Society.
17. Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R. Bushby, K 2002). Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disorders, 12 (10 926 929. (Pubitemid 35408673)
18. Emery, A 1991). Population frequencies of inherited neuromuscular diseases: A world survey. Neuromuscular Disorders, 1 (1 19 29.
19. Emery, A. E. Muntoni, F 2003). Duchenne muscular dystrophy (3rd ed Oxford : Oxford University Press.
20. English, K. Gibbs, J 2006). Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Developmental Medicine & Child Neurology, 48 (3 231 235. (Pubitemid 44404273)
21. Erb, W. H 1884). Über die "juvenile form" der progressiven muskelatrophie und ihre beziehungen zur sogenannten pseudohypertrophie der muskeln. Deutsches Archiv für klinische Medizin, 34, 467 519.
22. Feng, J., Schaus, B. J., Fallavollita, J. A., Lee, T. C. Canty, J. M., Jr. 2001). Preload induces troponin I degradation independently of myocardial ischemia. Circulation, 103 (16 2035 2037. (Pubitemid 32373003)
23. Finsterer, J. Stollberger, C 2003). The heart in human dystrophinopathies. Cardiology, 99 (1 1 19. (Pubitemid 36206630)
24. Frankel, K. Rosser, R 1976). The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Human Pathology, 7 (4 375 386.
25. Gao, W. D., Atar, D., Liu, Y., Perez, N. G., Murphy, A. M. Marban, E 1997). Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circulation Research, 80 (3 393 399. (Pubitemid 27093354)
26. Hoffman, E. P., Brown, R. H. Kunkel, L. M 1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919 928. (Pubitemid 18099471)
27. Hoffman, E. P., Hudecki, M. S., Rosenberg, P. A., Pollina, C. M. Kunkel, L. M 1988). Cell and fiber-type distribution of dystrophin. Neuron, 1 (5 411 420.
28. Ishikawa, Y., Bach, J. R., Ishikawa, Y. Minami, R 1995). A management trial for Duchenne cardiomyopathy. American Journal of Physical Medicine & Rehabilitation, 74 (5 345 350.
29. Jefferies, J. L., Eidem, B. W., Belmont, J. W., Craigen, W. J., Ware, S. M., Fernbach, S. D., et al 2005). Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation, 112 (18 2799 2804. (Pubitemid 41641674)
30. Kajimoto, H., Ishigaki, K., Okumura, K., Tomimatsu, H., Nakazawa, M., Saito, K., et al 2006). Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circulation Journal, 70 (8 991 994. (Pubitemid 44161734)
31. Kirchmann, C., Kececioglu, D., Korinthenberg, R. Dittrich, S 2005). Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatric Cardiology, 26 (1 66 72. (Pubitemid 41569564)
32. Koenig, M., Hoffman, E., Bertelson, C., Monaco, A., Feener, C. Kunkel, L 1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (Cambridge), 50 (3 509 517. (Pubitemid 18098338)
33. Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S. A., et al 2003). Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nature Medicine, 9 (8 1009 1014. (Pubitemid 37021780)
34. Lu, S. Hoey, A 2000). Age- and sex-associated changes in cardiac beta(1)-adrenoceptors from the muscular dystrophy (mdx) mouse. Journal of Molecular and Cellular Cardiology, 32 (9 1661 1668.
35. Matsumura, T., Saito, T., Fujimura, H. Shinno, S 2007). Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients. Brain and Development, 29 (8 496 501. (Pubitemid 47223612)
36. Melacini, P., Fanin, M., Danieli, G. A., Villanova, C., Martinello, F., Miorin, M., et al 1996). Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation, 94 (12 3168 3175. (Pubitemid 26427483)
37. Meryon, E 1851). On fatty degeneration of the voluntary muscles: Report of the Royal Medical and Chirurgical Society. Lancet, 2, 588 589.
38. Meune, C., Pascal, O., Becane, H. M., Heloire, F., Christoforou, D., Laforet, P., et al 2004). Reliable detection of early myocardial dysfunction by tissue Doppler echocardiography in Becker muscular dystrophy. Heart (British Cardiac Society), 90 (8 947 948. (Pubitemid 39005957)
39. Mori, K., Manabe, T., Nii, M., Hayabuchi, Y., Kuroda, Y. Tatara, K 2002). Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatric Cardiology, 23 (2 160 166. (Pubitemid 36927893)
40. Moxley, R. T., 3rd., Brooke, M. H., Fenichel, G. M., Mendell, J. R., Griggs, R. C., Miller, J. P., et al 1987). Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine. Muscle & Nerve, 10 (1 22 33. (Pubitemid 17223306)
41. Nakada, K., Miyazaki, J. Hirabayashi, T 2002). Expression of multiple troponin T isoforms in chicken breast muscle regeneration induced by sub-serous implantation. Differentiation; Research in Biological Diversity, 70 (2-3 92 100. (Pubitemid 38230559)
42. Naruse, H., Miyagi, J., Arii, T., Ohyanagi, M., Iwasaki, T. Jinnai, K 2004). The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: Five-year follow-up study. Annals of Nuclear Medicine, 18 (3 203 208. (Pubitemid 38899669)
43. Nigro, G., Comi, L., Politano, L., Limongelli, F., Nigro, V., De Rimini, M., et al 1995). Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle and Nerve, 18 (3 283 291.
44. Nigro, G., Politano, L., Passamano, L., Palladino, A., De Luca, F., Nigro, G., et al 2006). Cardiac treatment in neuro-muscular diseases. Acta Myologica, 25 (3 119 123. (Pubitemid 46579320)
45. Pernice, W., Beckmann, R., Ketelsen, U. P., Frey, M., Schmidt-Redemann, B., Haap, K. P., et al 1988). A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy. Klinische Wochenschrift, 66 (13 565 570. (Pubitemid 18223954)
46. Pillers, D. A., Bulman, D. E., Weleber, R. G., Sigesmund, D. A., Musarella, M. A., Powell, B. R., et al 1993). Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nature Genetics, 4 (1 82 86. (Pubitemid 23165919)
47. Ramaciotti, C., Heistein, L. C., Coursey, M., Lemler, M. S., Eapen, R. S., Iannaccone, S. T., et al 2006). Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. The American Journal of Cardiology, 98 (6 825 827. (Pubitemid 44301021)
48. Raymackers, J. M., Debaix, H., Colson-Van Schoor, M., De Backer, F., Tajeddine, N., Schwaller, B., et al 2003). Consequence of parvalbumin deficiency in the mdx mouse: Histological, biochemical and mechanical phenotype of a new double mutant. Neuromuscular Disorders, 13 (5 376 387. (Pubitemid 36687813)
49. Shimizu, T., Okamoto, H., Chiba, S., Matsui, Y., Sugawara, T., Onozuka, H., et al 2002). Long-term combined therapy with an angiotensin type I receptor blocker and an angiotensin converting enzyme inhibitor prolongs survival in dilated cardiomyopathy. Japanese Heart Journal, 43 (5 531 543. (Pubitemid 41519039)
50. Shirai, K., Watanabe, K., Ma, M., Wahed, M. I., Inoue, M., Saito, Y., et al 2005). Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy. Molecular and Cellular Biochemistry, 269 (1-2 137 142. (Pubitemid 40287811)
51. Suselbeck, T., Haghi, D., Neff, W., Borggrefe, M. Papavassiliu, T 2005). Midwall myocardial fibrosis in Becker-Kiener muscular dystrophy. Zeitschrift fur Kardiologie, 94 (7 465 468. (Pubitemid 40964975)
52. Tani, L. Y., Minich, L. L., Williams, R. V. Shaddy, R. E 2005). Ventricular remodeling in children with left ventricular dysfunction secondary to various cardiomyopathies. American Journal of Cardiology, 96 (8 1157 1161. (Pubitemid 41416613)
53. Toifl, K., Presterl, E. Graninger, W 1991). Ineffectiveness of diltiazem in Duchenne muscular dystrophy: A placebo-controlled double-blind study. Wiener Klinische Wochenschrift, 103 (8 232 235.
54. Townsend, D., Blankinship, M. J., Allen, J. M., Gregorevic, P., Chamberlain, J. S. Metzger, J. M 2007). Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Molecular Therapy, 15 (6 1086 1092. (Pubitemid 46813611)
55. Vita, G., Di Leo, R., De Gregorio, C., Papalia, A., Rodolico, C., Coglitore, S., et al 2001). Cardiovascular autonomic control in Becker muscular dystrophy. Journal of the Neurological Sciences, 186 (1-2 45 49. (Pubitemid 32544941)
56. Weber, K. T 1999). Angiotensin II and connective tissue: Homeostasis and reciprocal regulation. Regulatory Peptides, 82 (1-3 1 17. (Pubitemid 29308980)
57. Williams, I. A. Allen, D. G 2007). Intracellular calcium handling in ventricular myocytes from mdx mice. American Journal of Physiology, 292 (2 H846 H855. (Pubitemid 46246934)
58. Woolf, P. J., Lu, S., Cornford-Nairn, R., Watson, M., Xiao, X. H., Holroyd, S. M., et al 2006). Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. American Journal of Physiology, 290 (6 H2439 H2445. (Pubitemid 43846073)
59. Yasuda, S., Townsend, D., Michele, D. E., Favre, E. G., Day, S. M. Metzger, J. M 2005). Dystrophic heart failure blocked by membrane sealant poloxamer. Nature, 436 (7053 1025 1029. (Pubitemid 41191686)
60. Yue, Y., Li, Z., Harper, S. Q., Davisson, R. L., Chamberlain, J. S. Duan, D 2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation, 108 (13 1626 1632. (Pubitemid 37187791)
61. Zatz, M., Rapaport, D., Vainzof, M., Passos-Bueno, M., Bortolini, E., Pavanello Rde, C., et al 1991). Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. Journal of the Neurological Sciences, 102 (2 190 196.